Pharmaceuticals

• ImmunoGen licenses technology to Amgen for $1M
  AP (November 19, 2009)
  WALTHAM, Mass. (AP) - ImmunoGen Inc. said Thursday that Amgen Inc. licensed rights to a second potential cancer-treatment from the company for $1 million upfront.